20/20 GeneSystems
About this raise
20/20 GeneSystems, with a valuation of $69.86 million, is raising funds on Wefunder. It is a diagnostics company with a successful track record in cancer detection with its AI-powered multi-cancer blood test, OneTest. OneTest is a multi-cancer early detection test that measures antigens that tend to rise early in tumor development and enable early detection of cancer. The business has multiple issued or allowed patents in the US and East Asia and has partnered with a leading cancer center and a major supermarket chain for in-pharmacy testing. Jonathan Cohen founded 20/20 GeneSystems in May 2000. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $5 million. The campaign proceeds will be used for sales, marketing, R&D, and operational and administrative staffing to enable growth.
Investment Overview
Invested $555,661 :
Deal Terms
Company & Team
Company
- Year Founded
- 2000
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B/B2C
- Margin
- Medium
- Capital Intensity
- Low
Financials
- Revenue -87% YoY
- $1,424,304
- Monthly Burn
- $285,000
-
Runway
- 11.5 months
- Gross Margin
- 8%
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $5,495,980
- VC Backed?
- No
Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|
02/14/2025 | Wefunder | $69,859,000 | $555,661 | Equity - Preferred | Funded | RegCF |
12/21/2022 | StartEngine | $58,400,000 | $232,704 | Convertible Note | Funded | RegCF |
06/27/2021 | StartEngine | $38,500,000 | $2,903,017 | Equity - Preferred | Funded | RegA+ |
11/01/2020 | SeedInvest | $38,500,000 | $3,792,229 | Equity - Preferred | Funded | RegA+ |
12/14/2017 | Microventures | $23,000,000 | $1,064,807 | Equity - Preferred | Funded | RegCF |
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.